SAP30
Histone deacetylase complex subunit SAP30
Also known as: SAP30_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75446
- Gene
- SAP30
- Ensembl
- ENSG00000164105
- Chromosome
- 4
- Canonical length
- 220 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Histone acetylation plays a key role in the regulation of eukaryotic gene expression. Histone acetylation and deacetylation are catalyzed by multisubunit complexes. The protein encoded by this gene is a component of the histone deacetylase complex, which includes SIN3, SAP18, HDAC1, HDAC2, RbAp46, RbAp48, and other polypeptides. This complex is active in deacetylating core histone octamers, but inactive in deacetylating nucleosomal histones. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
220 residues, UniProt reviewed canonical sequence.
>O75446|SAP30
1 MNGFTPDEMS RGGDAAAAVA AVVAAAAAAA SAGNGTGAGT GAEVPGAGAV SAAGPPGAAG
61 PGPGQLCCLR EDGERCGRAA GNASFSKRIQ KSISQKKVKI ELDKSARHLY ICDYHKNLIQ
121 SVRNRRKRKG SDDDGGDSPV QDIDTPEVDL YQLQVNTLRR YKRHFKLPTR PGLNKAQLVE
181 IVGCHFRSIP VNEKDTLTYF IYSVKNDKNK SDLKVDSGVHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SAP30 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 40 nTPM
- colon: 24 nTPM
- spinal cord: 24 nTPM
- testis: 24 nTPM
- bone marrow: 22 nTPM
- urinary bladder: 21 nTPM
Single-cell type
- monocytes: 174 nCPM
- monocyte progenitors: 126 nCPM
- macrophages: 101 nCPM
- gastric progenitor cells: 95 nCPM
- kupffer cells: 77 nCPM
- schwann cells: 74 nCPM
Immune cell
- classical monocyte: 1.3 nTPM
- myeloid DC: 1 nTPM
- intermediate monocyte: 0.7 nTPM
- gdT-cell: 0.6 nTPM
- neutrophil: 0.5 nTPM
- T-reg: 0.5 nTPM
Brain region
- white matter: 37 nTPM
- medulla oblongata: 26 nTPM
- basal ganglia: 26 nTPM
- spinal cord: 25 nTPM
- cerebellum: 24 nTPM
- hypothalamus: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.31
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell migration
- negative regulation of stem cell population maintenance
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of stem cell population maintenance
- regulation of DNA-templated transcription
- skeletal muscle cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SAP30 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SAP30 as an antibody target. Whether an autoantibody or antibody against SAP30 could matter depends on whether native SAP30 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SAP30 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SAP30 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...